Lexeo Therapeutics, Inc.

LXEO

—

Advanced chart & tools →

Lexeo Therapeutics, Inc.LXEO

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-1.86

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$654,000

Net income

$-99.96M

Net margin

-15284.6%

Gross margin

—

Dividends & financials

Lexeo Therapeutics, Inc. (LXEO) reported revenue of $654,000 and net income of $-99.96M, or $-1.86 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.